These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 8894145)
1. Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study. Gutteridge DH; Retallack RW; Ward LC; Stuckey BG; Stewart GO; Prince RL; Kent GN; Bhagat CI; Price RI; Thompson RI; Nicholson GC Bone; 1996 Oct; 19(4):387-94. PubMed ID: 8894145 [TBL] [Abstract][Full Text] [Related]
2. Paget's disease: acquired resistance to one aminobisphosphonate with retained response to another. Gutteridge DH; Ward LC; Stewart GO; Retallack RW; Will RK; Prince RL; Criddle A; Bhagat CI; Stuckey BG; Price RI; Kent GN; Faulkner DL; Geelhoed E; Gan SK; Vasikaran S J Bone Miner Res; 1999 Oct; 14 Suppl 2():79-84. PubMed ID: 10510219 [TBL] [Abstract][Full Text] [Related]
3. Rapid, divergent changes in spinal and forearm bone density following short-term intravenous treatment of Paget's disease with pamidronate disodium. Price RI; Gutteridge DH; Stuckey BG; Kent GN; Retallack RW; Prince RL; Bhagat CI; Johnston CA; Nicholson GC; Stewart GO J Bone Miner Res; 1993 Feb; 8(2):209-17. PubMed ID: 8442439 [TBL] [Abstract][Full Text] [Related]
6. Pamidronate is effective for Paget's disease of bone refractory to conventional therapy. Wimalawansa SJ; Gunasekera RD Calcif Tissue Int; 1993 Oct; 53(4):237-41. PubMed ID: 8275351 [TBL] [Abstract][Full Text] [Related]
7. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone. Walsh JP; Ward LC; Stewart GO; Will RK; Criddle RA; Prince RL; Stuckey BG; Dhaliwal SS; Bhagat CI; Retallack RW; Kent GN; Drury PJ; Vasikaran S; Gutteridge DH Bone; 2004 Apr; 34(4):747-54. PubMed ID: 15050907 [TBL] [Abstract][Full Text] [Related]
8. Treatment of Paget's disease of bone with single dose intravenous pamidronate. Watts RA; Skingle SJ; Bhambhani MM; Pountain G; Crisp AJ Ann Rheum Dis; 1993 Aug; 52(8):616-8. PubMed ID: 8215628 [TBL] [Abstract][Full Text] [Related]
9. Clinical experience with pamidronate in the treatment of Paget's disease of bone. Gallacher SJ; Boyce BF; Patel U; Jenkins A; Ralston SH; Boyle IT Ann Rheum Dis; 1991 Dec; 50(12):930-3. PubMed ID: 1768163 [TBL] [Abstract][Full Text] [Related]
10. Effects of intravenous pamidronate therapy on Paget's disease of bone. Bombassei GJ; Yocono M; Raisz LG Am J Med Sci; 1994 Oct; 308(4):226-33. PubMed ID: 7942981 [TBL] [Abstract][Full Text] [Related]
11. Prevention of appendicular bone loss in Paget's disease following treatment with intravenous pamidronate disodium. Stewart GO; Gutteridge DH; Price RI; Ward L; Retallack RW; Prince RL; Stuckey BG; Kent GN; Bhagat CI; Dhaliwal SS Bone; 1999 Feb; 24(2):139-44. PubMed ID: 9951784 [TBL] [Abstract][Full Text] [Related]
12. Intravenously administered pamidronate in the treatment of Paget's disease of bone. Tucci JR; Bontha S Endocr Pract; 2001; 7(6):423-9. PubMed ID: 11747277 [TBL] [Abstract][Full Text] [Related]
13. Paget's disease of bone: benefits of neridonate as a first treatment and in cases of relapse after clodronate. Filipponi P; Cristallini S; Policani G; Casciari C; Gregorio F Bone; 1998 Dec; 23(6):543-8. PubMed ID: 9855463 [TBL] [Abstract][Full Text] [Related]
14. Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD). Harinck HI; Papapoulos SE; Blanksma HJ; Moolenaar AJ; Vermeij P; Bijvoet OL Br Med J (Clin Res Ed); 1987 Nov; 295(6609):1301-5. PubMed ID: 3120987 [TBL] [Abstract][Full Text] [Related]
15. Determinants of remission of Paget's disease of bone. Patel S; Stone MD; Coupland C; Hosking DJ J Bone Miner Res; 1993 Dec; 8(12):1467-73. PubMed ID: 8304048 [TBL] [Abstract][Full Text] [Related]
16. Patterns of pain in Paget's disease of bone and their outcomes on treatment with pamidronate. Vasireddy S; Talwalkar A; Miller H; Mehan R; Swinson DR Clin Rheumatol; 2003 Dec; 22(6):376-80. PubMed ID: 14677009 [TBL] [Abstract][Full Text] [Related]
17. Changes in serum HDL and LDL cholesterol in patients with Paget's bone disease treated with pamidronate. Montagnani A; Gonnelli S; Cepollaro C; Campagna MS; Franci MB; Pacini S; Gennari C Bone; 2003 Jan; 32(1):15-9. PubMed ID: 12584031 [TBL] [Abstract][Full Text] [Related]
18. Intravenous pamidronate in Paget's disease--response is dependent on radiographic and biochemical severity. Stuckey BG; Gutteridge DH; Stewart GO; Prince RL; Ward LC; Kent GN; Prince RI; Retallack RW; Bhagat CI; Nicholson GC Semin Arthritis Rheum; 1994 Feb; 23(4):286. PubMed ID: 8009263 [No Abstract] [Full Text] [Related]
19. Bone density changes in Paget's disease 2 years after iv pamidronate: profound, sustained increases in pagetic bone with severity-related loss in forearm nonpagetic cortical bone. Gutteridge DH; Retallack RW; Ward LC; Price RI; Stewart GO; Stuckey BG; Prince RL; Kent GN; Bhagat CI; Thompson RI; Nicholson GC Bone; 2003 Jan; 32(1):56-61. PubMed ID: 12584036 [TBL] [Abstract][Full Text] [Related]